Capital International Investors Astrazeneca PLC Transaction History

Capital International Investors

$483 Billion
Q1 2024

A detailed history of Capital International Investors transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital International Investors holds 34,521,875 shares of AZN stock, worth $2.69 Billion. This represents 0.48% of its overall portfolio holdings.

Number of Shares

34,521,875

Previous 34,782,762 0.75%

Holding current value

$2.69 Billion

Previous $2.34 Billion 0.16%

% of portfolio

0.48%

Previous 0.54%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $15.9 Million - $18.1 Million	-260,887 Reduced 0.75%	34,521,875 $2.34 Billion
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $10.2 Million - $11.4 Million	164,183 Added 0.47%	34,782,762 $2.34 Billion
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $241 Million - $267 Million	-3,721,186 Reduced 9.71%	34,618,579 $2.34 Billion
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $14.8 Million - $16 Million	211,055 Added 0.55%	38,339,765 $2.74 Billion
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $169 Million - $191 Million	-2,669,638 Reduced 6.54%	38,128,710 $2.65 Billion

Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $25.6 Million - $33.3 Million	472,725 Added 1.17%	40,798,348 $2.77 Billion
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $50 Million - $128 Million	942,624 Added 2.39%	40,325,623 $2.21 Billion
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $142 Million - $170 Million	2,389,335 Added 6.46%	39,382,999 $2.61 Billion
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $89.4 Million - $108 Million	1,604,875 Added 4.53%	36,993,664 $2.46 Billion
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $30 Million - $35.5 Million	555,607 Added 1.6%	35,388,789 $2.06 Billion
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $155 Million - $169 Million	2,783,859 Added 8.69%	34,833,182 $2.09 Billion
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $93.7 Million - $117 Million	1,935,945 Added 6.43%	32,049,323 $1.92 Billion
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $195 Million - $225 Million	4,124,723 Added 15.87%	30,113,378 $1.5 Billion
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $158 Million - $189 Million	-3,260,811 Reduced 11.15%	25,988,655 $1.3 Billion
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $31.3 Million - $36 Million	-589,160 Reduced 1.97%	29,249,466 $1.6 Billion
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $65.2 Million - $83.7 Million	1,513,006 Added 5.34%	29,838,626 $1.58 Billion
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $203 Million - $276 Million	5,375,926 Added 23.42%	28,325,620 $1.27 Billion
Q4 2019 Feb 18, 2020	BUY	$42.46 - $50.46 $268 Million - $319 Million	6,319,420 Added 38.0%	22,949,694 $1.14 Billion
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $140,420 - $159,145	3,500 Added 0.02%	16,630,274 $741 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $200 Million - $224 Million	5,375,863 Added 47.78%	16,626,774 $686 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $30,024 - $36,394	846 Added 0.01%	11,250,911 $455 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $55.2 Million - $62.1 Million	1,497,478 Added 15.35%	11,250,065 $427 Million
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $11.1 Million - $12.7 Million	319,416 Added 3.39%	9,752,587 $386 Million
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $8,844 - $9,484	256 Added 0.0%	9,433,171 $331 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $17.6 Million - $19.5 Million	-533,495 Reduced 5.35%	9,432,915 $330 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $41,717 - $45,214	-1,300 Reduced 0.01%	9,966,410 $346 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $289 Million - $339 Million	9,967,710	9,967,710 $338 Million

Others Institutions Holding AZN

# of Institutions

1,244

Shares Held

477M

Call Options Held

5.99M

Put Options Held

5.24M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $242B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account

Capital International Investors Astrazeneca PLC Transaction History